We are live on ! Find out more
IUHSA

Itau Unibanco Holding S.A. Portfolio holdings

AUM $4.31B
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+4.24%
1 Year Est. Return
+46.57%
3 Year Est. Return
+107.3%
5 Year Est. Return
+125.12%
10 Year Est. Return
+406.64%
AUM
$2.12B
AUM Growth
-$91.8M
Cap. Flow
-$374M
Cap. Flow %
-17.67%
Top 10 Hldgs %
56.94%
Holding
871
New
284
Increased
261
Reduced
132
Closed
187

Sector Composition

Rank Sector Weight
1 Financials 30.49%
2 Energy 10.03%
3 Materials 7.41%
4 Consumer Discretionary 4.77%
5 Consumer Staples 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
576
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$15K ﹤0.01%
336
-1,113
-77% -$62.7K
AA icon
577
Alcoa
AA
$13.2B
$14K ﹤0.01%
609
-918
-60% -$22.9K
ZWS icon
578
Zurn Elkay Water Solutions
ZWS
$8.53B
$14K ﹤0.01%
+972
New +$13.1K
FTSV
579
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$14K ﹤0.01%
1,285
-1,018
-44% -$14.9K
SNDX icon
580
Syndax Pharmaceuticals
SNDX
$1.82B
$13K ﹤0.01%
1,423
-1,205
-46% -$8.78K
TEAM icon
581
Atlassian
TEAM
$37.8B
$13K ﹤0.01%
102
-129
-56% -$15.5K
WVE icon
582
Wave Life Sciences
WVE
$1.2B
$13K ﹤0.01%
+487
New +$13.7K
BOLD
583
DELISTED
Audentes Therapeutics, Inc
BOLD
$13K ﹤0.01%
336
-457
-58% -$17.6K
ALNY icon
584
Alnylam Pharmaceuticals
ALNY
$29.3B
$12K ﹤0.01%
166
-189
-53% -$14.5K
CBIO
585
Crescent Biopharma
CBIO
$626M
$11K ﹤0.01%
9
-25
-74% -$29.9K
MYOV
586
DELISTED
Myovant Sciences Ltd.
MYOV
$11K ﹤0.01%
+1,220
New +$18.2K
BCEL
587
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$10K ﹤0.01%
+513
New +$9.26K
KPTI icon
588
Karyopharm Therapeutics
KPTI
$48M
$9K ﹤0.01%
96
-80
-45% -$6.42K
LQD icon
589
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$9K ﹤0.01%
75
CTMX icon
590
CytomX Therapeutics
CTMX
$754M
$8K ﹤0.01%
756
-650
-46% -$6.81K
HRTX icon
591
Heron Therapeutics
HRTX
$92.9M
$8K ﹤0.01%
423
-337
-44% -$6.73K
ALDR
592
DELISTED
Alder Biopharmaceuticals
ALDR
$7K ﹤0.01%
+618
New +$7.48K
KALA icon
593
KALA BIO
KALA
$14.5M
-1
Closed -$16.6K
PHAS
594
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$6K ﹤0.01%
+432
New +$5.29K
BBD icon
595
PUT
Banco Bradesco
BBD
$36.7B
$5K ﹤0.01%
+13,310
New +$90.9K
RIGL icon
596
Rigel Pharmaceuticals
RIGL
$750M
$5K ﹤0.01%
189
-149
-44% -$3.36K
ASMB icon
597
Assembly Biosciences
ASMB
$529M
$4K ﹤0.01%
24
-24
-50% -$4.56K
HWM icon
598
CALL
Howmet Aerospace
HWM
$112B
$4K ﹤0.01%
+1,660
New +$28K
RCUS icon
599
Arcus Biosciences
RCUS
$3.64B
$4K ﹤0.01%
464
-371
-44% -$3.71K
RMD icon
600
CALL
ResMed
RMD
$30.7B
$4K ﹤0.01%
+982
New +$109K

Similar funds

Itau Unibanco Holding S.A.'s Q2 2019 Portfolio in Review

As of Q2 2019, Itau Unibanco Holding S.A. held 871 positions worth $2.12B, down 4.2% from $2.21B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Itau Unibanco Holding S.A. withdrew a net $374M in Q2 2019, closing 187 positions and reducing 132 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $104M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 20% a quarter earlier, followed by Energy and Materials.

Against the trend, Itau Unibanco Holding S.A. opened a new position in iShares 10-20 Year Treasury Bond ETF worth $49.8M.

  • Itau Unibanco Holding S.A.'s largest Q2 2019 buy was iShares 10-20 Year Treasury Bond ETF: 348,236 shares worth $49.8M.
  • Itau Unibanco Holding S.A. added most to Vanguard S&P 500 ETF in Q2 2019, an estimated $66.6M increase.
  • Itau Unibanco Holding S.A.'s biggest Q2 2019 reduction was Vanguard FTSE Europe ETF, cutting an estimated $122M.
  • Itau Unibanco Holding S.A. fully exited Alphabet (Google) Class C in Q2 2019, selling an estimated $104M.
  • Itau Unibanco Holding S.A.'s ten largest holdings make up 57% of its $2.12B portfolio in Q2 2019.
  • Itau Unibanco Holding S.A. opened 284 new positions and closed 187 in Q2 2019.
  • Itau Unibanco Holding S.A.'s portfolio value fell 4.2% quarter-over-quarter to $2.12B.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2019, filed 14 Aug 2019.